PREVALENCE OF HEPATITIS B AND HEPATITIS C VIRUS INFECTIONS IN POTENTIAL BLOOD DONORS IN

Abstract. The aims of the present study were to provide accurate prevalence of acute and occult hepatis B infection and hepatis C infection among potential blood donors in Cambodia and to study the accuracy of ELISA tests used for blood donor screening. A cross-sectional study was performed on sampl...

Full description

Bibliographic Details
Main Authors: Ha Sam Ol, Bjoern Bjoerkvoll, Sin Sothy, Yang Van Heng, Hedda Hoel, Anne Husebekk, Tore Gutteberg, Stig Larsen, Hans Husum
Other Authors: The Pennsylvania State University CiteSeerX Archives
Format: Text
Language:English
Published: 2009
Subjects:
Online Access:http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.611.2922
http://www.tm.mahidol.ac.th/seameo/2009-40-5/14-4568.pdf
Description
Summary:Abstract. The aims of the present study were to provide accurate prevalence of acute and occult hepatis B infection and hepatis C infection among potential blood donors in Cambodia and to study the accuracy of ELISA tests used for blood donor screening. A cross-sectional study was performed on samples collected from potential volunteer blood donors (n = 1,200) in two districts in rural Cambodia. The samples were tested using the ELISA technique for HBsAg, anti-HBc, and anti-HCV at a local blood bank. To validate the ELISA outcomes, a subset (n = 319) was analyzed by Automated Chemi-luminescent Microparticle Immunoassay Technique (CMIA) at the University Hospi-tal North Norway. The overall prevalence of the HBsAg positives was 7.7 % (95 % CI 6.2-9.3); the prevalence of anti-HBc positive samples was 58.6 % (95 % CI 55.8-61.4), and the prevalence of anti-HCV positive samples was 14.7 % (95 % CI 12.7-16.7). The prevalence rate of samples being both HBsAg positive and anti-HBc positive was 7.3% (95%CI 5.9- 9.0), and the prevalence rate of HBsAg negative and anti-HBc positive samples was 51.2 % (95%CI 48.4- 54.1). The overall agreement between the ELISA and the CMIA test results was very high both for HBsAg and anti-HBc (kappa 0.93), and